In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.
Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be vaccinated against COVID-19.
A Texas A&M study found key differences in the rates at which individuals in rural and urban areas wear face coverings in public and work from home.
Five campus testing locations will offer expanded hours through Feb. 27.
School of Public Health Dean Shawn Gibbs has led national and international research, training and policy related to responses to highly infectious diseases.
Convincing people to get vaccinated will be key to reaching herd immunity, a Texas A&M expert says.
Testing availability, vaccine information and volunteer opportunities are outlined in this update.
A Texas A&M geography professor is part of a research team that found efficient ways to track the virus and pinpoint spreading clusters.
The three-step process is mandatory for students who live on campus or work for the university. All Aggies are strongly encouraged to get tested.
Texas A&M employees have four more days to be tested. The new deadline to upload test results is Jan. 19.
The federal government reserved capacity at the FUJIFILM Diosynth Biotechnologies facility in College Station to manufacture vaccines through the end of 2021.